A Phase 1 Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Antigenically Central (AC)-Anhui mRNA-LNP Vaccine in Healthy Adults 25CTA-DM0002
Clinical Trial Grant
Awarded By
Leidos Biomedical Research, Inc.
Start Date
June 5, 2025
End Date
June 30, 2026
Awarded By
Leidos Biomedical Research, Inc.
Start Date
June 5, 2025
End Date
June 30, 2026